Moreover, CXCL1 levels in the blood are positively associated with both vascular endothelial growth factor (VEGF) levels and bone marrow microvessel density (MVD) in MM patients, suggesting a connection between CXCL1 and angiogenesis within the bone marrow [47]. The gene discussed is CXCL1; the disease is Miyoshi myopathy.